Literature DB >> 12920632

Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis.

Przemyslaw Sikora1, Sara Glatz, Bodo B Beck, Ludwig Stapenhorst, Malgorzata Zajaczkowska, Albrecht Hesse, Bernd Hoppe.   

Abstract

A crucial role for cell-crystal interactions in the development of urolithiasis (UL) and nephrocalcinosis (NC) was previously observed in experiments with different cell lines mimicking renal epithelial cells. It was found that such cell-crystal interactions lead to tubular damage and/or or dysfunction. To find further proof for these observations, we measured the urinary N-acetyl-beta- d-glucosaminidase (NAG) excretion, a marker of proximal tubular damage, in children with UL or NC and in children with an increased risk of UL. We enrolled 142 children aged 4-16 years (mean 9.67+/-3.40 years), with 50 children having UL, 30 children with a history of UL (ULH), 20 patients with NC, 34 children with secondary hyperoxaluria (HyOx), and 8 children with idiopathic hypercalciuria (HC). Normal urinary NAG/Cr values were determined in a group of 70 healthy children aged 4-16 years (mean 10.06+/-3.97 years). The urinary NAG activity was measured using a colorimetric method and the results were expressed as molar creatinine (Cr) ratios. The highest median NAG/Cr ratios were found in children with UL plus hematuria (0.72 U/mM) and in children with UL (0.67 U/mM) or NC (0.48 U/mM), which were all significantly higher than those in controls (0.28 U/mmol, P<0.001 and P<0.05). The NAG/Cr ratios were increased above the upper normal reference interval of 0.63 U/mM (95th percentile) in 28 of 50 (56%) children with UL and in 9 of 20 (45%) children with NC. Although the ULH group also had significantly higher median NAG/Cr ratios (0.36 U/mM) compared with controls, the NAG/Cr ratio was only elevated in 4 of 30 (13%) patients. NAG values in children with secondary HyOx or HC were not different from controls. No correlation was found between the NAG/Cr ratios and the urinary excretion of oxalate or calcium. In conclusion, UL or NC may result in proximal tubular injury, which is rather the consequence of disease activity and of the mechanical influence of calculi, than of the metabolic background. The mechanism of cell damage in these conditions however, seems to be complex. Neither HyOx nor HC alone were sufficient to induce severe tubular damage expressed as an increase in NAG excretion in our patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920632     DOI: 10.1007/s00467-003-1229-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

Review 1.  Renal cell-urinary crystal interactions.

Authors:  J C Lieske; F G Toback
Journal:  Curr Opin Nephrol Hypertens       Date:  2000-07       Impact factor: 2.894

2.  Urinary calcium oxalate saturation in healthy infants and children.

Authors:  B Hoppe; A Jahnen; D Bach; A Hesse
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

3.  Cell injury associated calcium oxalate crystalluria.

Authors:  R L Hackett; P N Shevock; S R Khan
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

Review 4.  Nephrocalcinosis.

Authors:  N D Adams; J C Rowe
Journal:  Clin Perinatol       Date:  1992-03       Impact factor: 3.430

5.  Increased urinary excretion of lipids by patients with kidney stones.

Authors:  S R Khan; P A Glenton
Journal:  Br J Urol       Date:  1996-04

6.  Intranephronic calculosis: its significance and relationship to matrix in nephrolithiasis.

Authors:  R S Malek; W H Boyce
Journal:  J Urol       Date:  1973-04       Impact factor: 7.450

7.  N-acetyl-beta-D-glucosaminidase excretion in calcium oxalate stone patients and its relation to the risk of stone formation.

Authors:  P Winter; K Ganter; D Heimbach; A Hesse
Journal:  Scand J Urol Nephrol       Date:  1996-12

8.  [Determination of enzyme activities in urine of patients with calcium oxalate calculi].

Authors:  J H Prinsen; H Günther; J Breuer
Journal:  J Clin Chem Clin Biochem       Date:  1986-12

9.  A new model of nephrolithiasis involving tubular dysfunction/injury.

Authors:  S Kumar; D Sigmon; T Miller; B Carpenter; S Khan; R Malhotra; C Scheid; M Menon
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

10.  Tubulopathy in nephrolithiasis: consequence rather than cause.

Authors:  P Jaeger; L Portmann; J M Ginalski; A F Jacquet; E Temler; P Burckhardt
Journal:  Kidney Int       Date:  1986-02       Impact factor: 10.612

View more
  6 in total

1.  A clinical study of renal tubular dysfunction in Cleistanthus collinus (Oduvanthalai) poisoning.

Authors:  Keshavan Nampoothiri; Anugrah Chrispal; Anisa Begum; Sudha Jasmine; Kango Gopal Gopinath; Anand Zachariah
Journal:  Clin Toxicol (Phila)       Date:  2010-03       Impact factor: 4.467

2.  Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.

Authors:  Larisa Kovacevic; Hong Lu; Joseph A Caruso; Yegappan Lakshmanan
Journal:  Urology       Date:  2016-02-15       Impact factor: 2.649

3.  Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.

Authors:  Mehmet Taşdemir; Dilara Fuçucuoğlu; Suat Hayri Küçük; Meltem Erol; Özgül Yiğit; Ilmay Bilge
Journal:  Clin Exp Nephrol       Date:  2017-06-26       Impact factor: 2.801

4.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

5.  Determination of Clara cell protein urinary elimination as a marker of tubular dysfunction.

Authors:  Ascensión Martín-Granado; Carmen Vázquez-Moncholí; María Isabel Luis-Yanes; Marisela López-Méndez; Víctor García-Nieto
Journal:  Pediatr Nephrol       Date:  2009-01-17       Impact factor: 3.714

6.  Distribution of urinary N-acetyl-beta-D-glucosaminidase and the establishment of reference intervals in healthy adults.

Authors:  Qian Liu; Ruyuan Zong; Huan Li; Xiaoxiao Yin; Mei Fu; Li Yao; Jin Sun; Fumeng Yang
Journal:  J Clin Lab Anal       Date:  2021-03-11       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.